Non-hodgkin Lymphoma
📧 Sign up to get email alerts when something new happens for Non-hodgkin Lymphoma.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2011-07-26Clinical Trial Update: Study of VELCADE and Rituximab in Patients With Relapsed or Refractory B-cell Non-Hodgkin's Lymphoma [Phase 3]
A Phase 3 trial evaluating Velcade (bortezomib) in combination with Rituximab for relapsed or refractory B-cell non-Hodgkin lymphoma has bee…
-
CLINICAL_TRIALS trial_result · 2011-07-13Clinical Trial Update: An Open-Label Study to Assess the Effect of CYP3A4 Induction on the Pharmacokinetics of VELCADE (Bortezomib) [Phase 1]
This completed Phase 1 open-label study assessed whether CYP3A4 induction alters the pharmacokinetics of bortezomib (Velcade) in patients wi…
-
CLINICAL_TRIALS trial_result · 2011-06-06Clinical Trial Update: Pilot Study of Bortezomib, Bendamustine and Rituximab on Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 pilot trial evaluating a combination of bortezomib, bendamustine, and rituximab in non-Hodgkin lymphoma; results were posted in 2011…
-
CLINICAL_TRIALS trial_result · 2011-06-02Clinical Trial Update: Clinical and Pathologic Studies in Non-Hodgkin's Lymphoma Patients Receiving Antibody Treatment [NA]
This clinical trial update notes completion of studies in Non-Hodgkin lymphoma patients treated with an antibody therapy.
-
CLINICAL_TRIALS trial_result · 2011-05-23Clinical Trial Update: A Study to Evaluate the Effect of Weekly PROCRIT (Epoetin Alfa) or Placebo on Anemia and Quality of Life in Children With Cancer Undergoing Chemotherapy [Phase 3]
A Phase 3 study evaluating weekly epoetin alfa (PROCRIT) versus placebo for anemia and quality of life in children receiving chemotherapy fo…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2011-05-17Clinical Trial Update: FR901228 in Treating Patients With Myelodysplastic Syndrome, Acute Myeloid Leukemia, or Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 clinical trial evaluating romidepsin (FR901228) in patients with myelodysplastic syndromes, acute myeloid leukemia, or non-Hodgkin l…
-
CLINICAL_TRIALS trial_result · 2011-05-03Clinical Trial Update: Ifosfamide/Carboplatin/Etoposide/Rituxan Followed by Zevalin in Relapsed/Refractory Intermediate Grade B-Cell Lymphoma [Phase 2]
A Phase 2 trial assessing a chemotherapy regimen (Ifosfamide, Carboplatin, Etoposide) with Rituximab followed by Zevalin for relapsed/refrac…
-
CLINICAL_TRIALS trial_result · 2011-04-21Clinical Trial Update: AIDS and Cancer Specimen Bank (ACSB)
AIDS and Cancer Specimen Bank (ACSB) clinical trial update shows the study status is COMPLETED. The listed conditions include AIDS-related K…
-
CLINICAL_TRIALS trial_result · 2011-03-29Clinical Trial Update: VP and G-CSF With or Without Rituximab in Autologous Peripheral Stem Cell Transplant For NHL [NA]
This completed clinical trial evaluated VP and G-CSF with or without Rituximab as part of autologous peripheral stem cell transplantation fo…
-
CLINICAL_TRIALS trial_result · 2011-03-14Clinical Trial Update: DepoCyt for Active Lymphomatous or Leukemic Meningitis [Phase 2]
Phase 2 trial of DepoCyt (liposomal cytarabine) for active lymphomatous or leukemic meningitis was terminated; results were posted in 2011.
-
CLINICAL_TRIALS trial_result · 2011-03-08Clinical Trial Update: The Effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in Cancer Patients [NA]
The study evaluating the effectiveness of the Screening Inventory of Psychosocial Problems (SIPP) in cancer patients has completed. It was s…
-
CLINICAL_TRIALS trial_result · 2011-01-28Clinical Trial Update: Non-randomized Safety Study With Bortezomib/Rituximab in Relapsed/Refractory Indolent Lymphoma [Phase 2]
This document reports the completion of a Phase 2 non-randomized safety study evaluating the combination of Bortezomib and Rituximab in rela…
-
CLINICAL_TRIALS trial_result · 2011-01-17Clinical Trial Update: Oral Combination Chemotherapy in Treating Elderly Patients With Intermediate or High-Grade Non-Hodgkin's Lymphomas [Phase 2]
Phase 2 trial evaluating an oral combination chemotherapy for elderly patients with intermediate- or high-grade Non-Hodgkin lymphoma has bee…
-
CLINICAL_TRIALS trial_result · 2011-01-07Clinical Trial Update: Mechanism of Action of Galiximab in Subjects With Previously Untreated Follicular Non-Hodgkin's Lymphoma [Phase 1]
Phase 1 study evaluating the mechanism of action of galiximab in previously untreated follicular non-Hodgkin's lymphoma; the trial status is…
-
CLINICAL_TRIALS trial_result · 2010-12-30Clinical Trial Update: Rituximab and Chemotherapy Followed by Ibritumomab Tiuxetan as Treatment for Low Grade Follicular Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial evaluating Rituxan (rituximab) and chemotherapy followed by Zevalin (ibritumomab tiuxetan) for low-grade follicular non-Hodgki…
-
CLINICAL_TRIALS trial_result · 2010-12-21Clinical Trial Update: External Beam Radiotherapy and Zevalin for Management of Indolent B-Cell Non-Hodgkin's Lymphoma [Phase 1]
A Phase 1 study at the Cleveland Clinic evaluated combining external beam radiotherapy with Zevalin (ibritumomab tiuxetan) for indolent B-ce…
-
CLINICAL_TRIALS trial_result · 2010-12-09Clinical Trial Update: Vorinostat and Lenalidomide in Treating Patients With Relapsed or Refractory Hodgkin Lymphoma or Non-Hodgkin Lymphoma [Phase 1]
A Phase 1 clinical trial update describes the combination of vorinostat and lenalidomide in patients with relapsed or refractory Hodgkin lym…
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: Treatment With AMD3100 (Plerixafor) in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients [Phase 2]
Phase 2 trial of plerixafor (AMD3100) in patients with Non-Hodgkin lymphoma and multiple myeloma has completed with results posted in 2010.
-
CLINICAL_TRIALS trial_result · 2010-11-25Clinical Trial Update: AMD3100 (Plerixafor) Given to NHL and MM Patients to Increase the Number of PBSCs When Given a Mobilizing Regimen of G-CSF [Phase 2]
This Phase 2 trial evaluates using plerixafor (AMD3100) with G-CSF to enhance mobilization of peripheral blood stem cells in patients with m…
-
CLINICAL_TRIALS trial_result · 2010-11-24Clinical Trial Update: Mobilization of Stem Cells With AMD3100 (Plerixafor) and G-CSF in Non-Hodgkin's Lymphoma and Multiple Myeloma Patients [Phase 2]
A Phase 2 trial evaluated stem cell mobilization using AMD3100 (plerixafor) plus G-CSF in patients with non-Hodgkin lymphoma and multiple my…
-
CLINICAL_TRIALS trial_result · 2010-11-17Clinical Trial Update: Vaccine Therapy Following Chemotherapy & Peripheral Stem Cell Transplantation in Treating Non-Hodgkin's Lymphoma [Phase 2]
Phase 2 trial update on a vaccine therapy given after chemotherapy and peripheral stem cell transplantation for non-Hodgkin's lymphoma has b…
-
CLINICAL_TRIALS trial_result · 2010-10-11Clinical Trial Update: Allo BMT in Advanced Leukemia or High Grade Lymphoma [NA]
Stanford University reports completion of a clinical trial evaluating allogeneic bone marrow transplant in patients with advanced leukemia o…
-
CLINICAL_TRIALS trial_result · 2010-10-08Clinical Trial Update: A Study of Primary Prophylaxis With Neulasta (Pegfilgrastim) Versus Secondary Prophylaxis After Chemotherapy in Elderly Subjects (>/= 65 Years Old) With Cancer [Phase 4]
Phase 4 clinical trial comparing primary prophylaxis with Neulasta (pegfilgrastim) to secondary prophylaxis after chemotherapy in elderly ca…
-
CLINICAL_TRIALS trial_result · 2010-10-07Clinical Trial Update: Assess the Oral Bioavailability of New ABT-263 Formulations [Phase 1]
Phase 1 pharmacokinetic study assessing oral bioavailability of new ABT-263 formulations.
-
CLINICAL_TRIALS trial_result · 2010-10-01Clinical Trial Update: Combination Chemotherapy and Bone Marrow and/or Peripheral Stem Cell Transplantation in Treating Patients With Non-Hodgkin's Lymphoma [Phase 2]
This Phase 2 trial evaluated combination chemotherapy with bone marrow and/or peripheral stem cell transplantation in patients with Non-Hodg…